Alterity Therapeutics

ATHE

3.1101.30% ( +0.040 )

Trading: Oct 9, 14:14:03 (EDT)

H2 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: Alterity Therapeutics(ATHE) the Revenue is 1.161 M (-72.08%), Miss estimate;the EBIT is -10.43 M (-230%), Miss estimate;the EPS is -0.52 (-143.5%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B72.08%

0.00B66.11%

-0.00B5.97%

EBITMiss expectations

-0.01B230.04%

-0.01B183.93%

-0.00B46.11%

EPSMiss expectations

-0.5196143.51%

-0.5067137.45%

-0.01296.06%

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly